Skip to main content
Log in

Nahrungsergänzungsmittel bei altersabhängiger Makuladegeneration

Aktuelle Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands – Oktober 2014

Supplements in age-related macular degeneration

Recommendations by the German Ophthalmological Society, the German Retina Society and the German Professional Association of Ophthalmologists – October 2014

  • Stellungnahmen und Empfehlungen
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Age-Related Eye Disease Study Research Group (2001) The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 132:668–681

    Article  Google Scholar 

  2. Bird AC, Bressler NM, Bressler SB et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39:367–374

    Article  CAS  PubMed  Google Scholar 

  3. Klein R, Davis MD, Magli YL et al (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98:1128–1134

    Article  CAS  PubMed  Google Scholar 

  4. Seddon JM, Sharma S, Adelman RA (2006) Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 113:260–266

    Article  PubMed  Google Scholar 

  5. Ferris FL III, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851

    Article  PubMed  Google Scholar 

  6. The Age-Related Eye Disease Study Research Group (1999) The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials 20:573–600

    Article  Google Scholar 

  7. Downie LE, Keller PR (2014) Nutrition and age-related macular degeneration: research evidence in practice. Optom Vis Sci 91:821–831

    Article  PubMed  Google Scholar 

  8. Zampatti S, Ricci F, Cusumano A et al (2014) Review of nutrient actions on age-related macular degeneration. Nutr Res 34:95–105

    Article  CAS  PubMed  Google Scholar 

  9. SanGiovanni JP, Chew EY (2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24:87–138

    Article  CAS  PubMed  Google Scholar 

  10. Sperduto RD, Ferris FL, Kurinij N (1990) Do we have a nutritional treatment for age-related cataract or macular degeneration? Arch Ophthalmol 108:1403–1405

    Article  CAS  PubMed  Google Scholar 

  11. Newsome DA, Swartz M, Leone NC et al (1988) Oral zinc in macular degeneration. Arch Ophthalmol 106:192–198

    Article  CAS  PubMed  Google Scholar 

  12. Schutt F, Pauleikhoff D, Holz FG (2002) Vitamins and trace elements in age-related macular degeneration. Current recommendations, based on the results of the AREDS study. Ophthalmologe 99:301–303

    Article  CAS  PubMed  Google Scholar 

  13. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436

    Article  Google Scholar 

  14. Grossklaus R, Henning KJ (2009) Vitamins for the eyes? Risks and opportunities for physician and patient. Ophthalmologe 106:521–526

    Article  CAS  PubMed  Google Scholar 

  15. Lonn E, Bosch J, Yusuf S et al (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347

    Article  PubMed  Google Scholar 

  16. Miller ER, Pastor-Barriuso R, Dalal D et al (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37–46

    Article  CAS  PubMed  Google Scholar 

  17. AREDS2 Group (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309:2005–2015

  18. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029–1035

    Article  Google Scholar 

  19. Omenn GS, Goodman GE, Thornquist MD et al (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150–1155

    Article  CAS  PubMed  Google Scholar 

  20. Ferris FL, Davis MD, Clemons TE et al (2005) A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123:1570–1574

    Article  PubMed  Google Scholar 

  21. Chew EY, Clemons TE, Agrón E et al (2013) Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology 120:1604–1611

    Article  PubMed Central  PubMed  Google Scholar 

  22. Chew EY, Clemons T, SanGiovanni JP et al (2012) The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology 119:2282–2289

    Article  PubMed Central  PubMed  Google Scholar 

  23. Aronow ME, Chew EY (2014) Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions. Curr Opin Ophthalmol 25:186–190

    Article  PubMed  Google Scholar 

  24. Evans JR, Lawrenson JG (2014) A review of the evidence for dietary interventions in preventing or slowing the progression of age-related macular degeneration. Ophthalmic Physiol Opt 34:390–396

    Article  PubMed  Google Scholar 

  25. Van Leeuwen R, Boekhoorn S, Vingerling JR et al (2005) Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294:3101–3107

    Article  Google Scholar 

Download references

Redaktionskomitee

[“Financial disclosure“ nach Vorgabe der Association for Research in Vision and Ophthalmology (ARVO): Kategorie 1: Unterstützung von Forschungsprojekten und klinischen Studien, Kategorie 2: Beratung, Honorare, Reisekosten]

Dr. med. Arno P. Göbel

Kat. 1: Heidelberg Engineering, Optos, Zeiss

Kat. 2: Novartis

Priv.-Doz. Dr. med. Monika Fleckenstein

Kat. 1: Acucela, Alcon, Allergan, Bayer, Genentech, Heidelberg Engineering, Novartis, Optos, Zeiss

Kat. 2: Bayer, Heidelberg Engineering, Novartis

Prof. Dr. med. Bernd Bertram

ø

Prof. Dr. med. Daniel Pauleikhoff

Kat. 1: Alcon, Allergan, Bayer, Genentech, Heidelberg Engineering, Novartis

Kat. 2: Allergan, Alcon, Bayer, Genentech, Heidelberg Engineering, Novartis, Roche

Prof. Dr. med. Horst Helbig

Kat. 1: Acucela, Allergan, Bayer, Novartis

Kat. 2: Alcon, Alimera, Allergan, Bayer, Heidelberg, Novartis

Prof. Dr. med. Frank G. Holz

Kat. 1: Acucela, Alcon, Allergan, Bayer, Genentech, Heidelberg Engineering, Novartis, Optos, Zeiss

Kat. 2: Acucela, Allergan, Alcon, Bayer, Genentech, Heidelberg Engineering, Novartis, Roche

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Consortia

Additional information

Diese Stellungnahme erscheint ebenfalls in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, Georg Thieme Verlag, Stuttgart.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deutsche Ophthalmologische Gesellschaft. Nahrungsergänzungsmittel bei altersabhängiger Makuladegeneration. Ophthalmologe 112, 35–40 (2015). https://doi.org/10.1007/s00347-014-3220-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-014-3220-z

Navigation